American Society of Hematology

How I Treat: Bringing Science to Clinical Dilemmas

Please check back next week for a more detailed preliminary schedule and program.

These sessions provide an opportunity for a small number of attendees to meet with a clinical expert in a setting that fosters interaction. Each year, ASH invites experts from around the world to facilitate informal discussions, allowing participants to present their questions and gain new perspectives on specific disease topics. A boxed lunch is provided.

Tickets are restricted to medical professionals only and are available on site on a first-come, first-served basis; no businesspersons or media will be admitted. Only one ticket per person is allowed.

Tickets may be purchased on site during registration hours beginning Thursday, November 29, at the Ticketed Sessions Counter in the San Diego Convention Center's Sails Pavilion.

Ticket Prices (per session)

Active or International Member$75
Non-Member$75
Associate, International Associate, Resident, or Graduate/Medical Student, or Honorary/Emeritus Member$50
Non-Member in Training$50
Allied Health Professional$50

Attention Trainees!

A number of tickets for these sessions will be reserved for trainees. Proof of status as an Associate, International Associate, Resident, or Graduate/Medical Student member, or Non-Member in Training will be required to purchase a ticket at the discounted rate.

A Renewed Focus on Hemolytic Anemias

Speaker:

Robert A. Brodsky, MD
Johns Hopkins University
Baltimore, MD

back to top

Anxiety Provoking “Benign” Hematology Consults

Speaker:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

back to top

In What Order Should I Give Therapy for Chronic Lymphocytic Leukemia?

Speaker:

Jennifer R. Brown, MD, PhD
Dana-Farber Cancer Institute
Newton, MA

back to top

New Standards or Old Standards for Treatment of Hodgkin Lymphoma

Speaker:

Alison J. Moskowitz, MD
Memorial Sloan Kettering Cancer Center
New York, NY

back to top

The Hematology Consultant’s Role in the Critical Care Environment

Speaker:

Lisa Baumann Kreuziger, MD, MS
BloodCenter of Wisconsin
Milwaukee, WI

back to top

Thrombotic Thrombocytopenic Purpura: How I Treat

Speaker:

Shruti Chaturvedi, MBBS,MS
Johns Hopkins University
Baltimore, MD

back to top

Treating Acute Myeloid Leukemia in Older Adults, and What Exactly Do We Mean by "Older"?

Speaker:

Laura C. Michaelis, MD
Medical College of Wisconsin
Milwaukee, WI

back to top

Treating Myelodysplastic Syndromes: From Clonal Hematopoiesis to Almost Acute Myeloid Leukemia

Speaker:

David P. Steensma, MD
Dana-Farber Cancer Institute
Boston, MA

back to top

What Factors Influence Choice of Therapy in Chronic Myeloid Leukemia?

Speaker:

Jane Apperley, MB ChB MD
Imperial College London
London, United Kingdom

back to top

When to Start Therapy in Myeloproliferative Neoplasms and What to Choose

Speaker:

Jason R. Gotlib, MD,MS
Stanford Cancer Center
Stanford, CA

Other Education Sessions

back to top